LACTOSE (INDIA)
Back to Cashflow Statement
|
LACTOSE (INDIA) Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-5.75 Cr | ₹-8.32 Cr | ₹-8.14 Cr | ₹4.52 Cr | ₹-3.57 Cr |
What is the latest Cash Flow from Financing Activities ratio of LACTOSE (INDIA) ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-5.75 Cr |
Mar2023 | ₹-8.32 Cr |
Mar2022 | ₹-8.14 Cr |
Mar2021 | ₹4.52 Cr |
Mar2020 | ₹-3.57 Cr |
How is Cash Flow from Financing Activities of LACTOSE (INDIA) Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-5.75 Cr | Negative | |
Mar2023 | ₹-8.32 Cr | Negative | |
Mar2022 | ₹-8.14 Cr | Negative | |
Mar2021 | ₹4.52 Cr | Positive | |
Mar2020 | ₹-3.57 Cr | - |
Compare Cash Flow from Financing Activities of peers of LACTOSE (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LACTOSE (INDIA) | ₹126.6 Cr | 1.6% | -0.6% | -46.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,069.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
LACTOSE (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LACTOSE (INDIA) | 1.6% |
-0.6% |
-46.4% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses